Cooper Companies Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
176 / 236
Position in country
10304 / 14179
Return on Assets, %
2.4
1.6
Net income margin, %
8.7
2.7
EBITDA margin, %
26.8
10.2
Debt to Equity, %
36
13.9
Intangible assets and goodwill, %
46.7
2.7
Revenue CAGR 3Y, %
13.9
11.3
Total Equity change 1Y, %
4.9
-0.3
Revenue Y, % chg
8.4
0
P/E
94.5
25.8
P/BV
2.4
1.5
P/S
5
2.8
EV/S
5.7
2.5
EV/EBITDA
22.1
9
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
17.6
36.5
Forward P/E
25.1
18.3
Forward Dividend Yield, %
0
0.2
Expected dividend per share
0
0
Payout Ratio, %
0.5
32.2
Competitors
Ranks
-
Lantheus Holdings Inc
00%
-
Rxsight Inc
00%
-
Merit Medical Systems Inc
00%
-
STAAR Surgical Co
00%
-
Align Technology Inc
00%
-
Haemonetics Corp
00%
-
DENTSPLY SIRONA Inc
00%
-
Cooper Companies Inc
00%
-
Neogen Corp
00%
-
ICU Medical Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
18587.6
Ticker
COO.OQ
ISIN
US2166485019
IPO date
1983-01-21
Availability on Russian exchanges
Yes
Reporting for
2024-03-01
Date fact. publication of reports
2024-01-31
Company Description
The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: